Orion Corporation, a globally operating pharmaceutical company, and Invenra an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, announced that they have...
Invenra Inc. is pleased to announce that its innovative bispecific antibody, INV724, developed for the treatment of neuroblastoma, has been awarded both Rare Pediatric...
